Advertisement
Home Tags Prescription Drugs

Tag: Prescription Drugs

Mandatory safety training for doctors who prescribe opioids is being reconsidered by the U.S. Food and Drug Administration.

FDA Reconsidering Training for Doctors Prescribing Opioids

0
Next week, FDA committee of outside experts will meet to review risk-management plans
Intermittent preventive administration of topical corticosteroids in children controls the severity of atopic dermatitis

Preventive Topical Steroids Cut Atopic Dermatitis Severity

0
May also prevent an increase in aeroallergen-specific IgE levels
For adolescents with polycystic ovarian syndrome

Review Compares Metformin, OCPs for Teens With PCOS

0
Four randomized controlled trials show benefits for metformin and oral contraceptive pills
For patients with relapsed

Ixazomib Ups Progression-Free Survival in Multiple Myeloma

0
Up in all prespecified patient groups, including those with high-risk cytogenetic abnormalities
Despite reported risks

Rates of Acid Suppression Med Rx Still Too High in NICUs

0
Meds in hospitalized high-risk infants linked to necrotizing enterocolitis, increased risk of death
HIV-positive transplant recipients and their physicians should be aware of potential interactions between fixed dose combination products used for HIV treatment and immunosuppressant metabolism

Interactions for HIV Drug Combos, Immunosuppressants

0
Drug interaction-induced calcineurin inhibitor nephrotoxicity described in renal transplant recipient
Pharmacists can do an effective job helping chronically ill patients manage their blood pressure

Pharmacists Can Manage Some Chronic Conditions Effectively

0
New legislation would establish pharmacists as health care providers
The drug eteplirsen should not be approved for treatment of Duchenne muscular dystrophy

FDA Panel Votes Against Approval of Eteplirsen for DMD

0
Clinical data did not meet the agency's requirements for well controlled studies necessary for approval
The addition of tiotropium to long-acting β2-agonists (LABA) and/or inhaled corticosteroids (ICS) does not reduce chronic obstructive pulmonary disease exacerbations compared to LABA/ICS alone

Triple Therapy No Benefit for COPD Exacerbations

0
Findings based long-acting β2-agonists, inhaled corticosteroids + tiotropium
Use of saxagliptin or sitagliptin is not associated with increased risk of hospitalized heart failure compared with other antihyperglycemic agents

Saxagliptin, Sitagliptin Don’t Up Hospitalized Heart Failure

0
No increased risk for new users of saxagliptin, sitagliptin versus other antihyperglycemic agents